News | News By Subject | News by Disease News By Date | Search News

Peripheral arterial disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial     10/4/2016
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Merck & Co., Inc. (MRK) Release: FDA Approves ZONTIVITY™ (Vorapaxar), First-In-Class PAR-1 Antagonist, For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack Or With Peripheral Arterial Disease     5/12/2014
Valentis, Inc. (VLTS) Ends Lead Drug Development After Mid-Stage Study Failure     7/11/2006
Vasogen (VSGN) Says Celacade Did Not Meet Phase 3 Primary Goal     3/13/2006
Dainippon Pharmaceutical, Sumitomo Pharmaceuticals Co. Ltd. And Ono Pharmaceutical Company, Ltd. To Enter Into Joint Development And Marketing Agreement For Limaprost Alfadex, Oral PGE1 Derivative     12/7/2005
Vasogen (VSGN) Gives Update On Phase III Celacade Trials     12/7/2005
Angiotech Pharmaceuticals (ANPI) Announces Acquisition Of Afmedica, Inc.     9/13/2005
Vasogen (VSGN) Stops Celacade Phase III Trial Early     8/30/2005
Endovasc Inc. (EVSC) Issues Update On Angiogenix; Cease Funding Research By Its Subsidiary, Angiogenix Limited, Inc.     5/26/2005
Endovasc Inc. (EVSC) Receives Feedback From The FDA Regarding Liprostin     5/2/2005
Sangamo BioSciences' (SGMO) Partner Edwards Lifesciences (EW) Files Investigational New Drug Application For Phase I/II "AVENGE" Clinical Trial     2/11/2004
NicOx SA (FR:N07413) Release: NCX 4016 Successfully Achieves Primary Efficacy Endpoint In Phase II Clinical Study Of Symptomatic Peripheral Arterial Obstructive Disease (PAOD)     1/8/2004

News from Around the Web

Press Releases
Bayer (BAY) Release: COMPASS Study Presented At ESC Congress 2017 – Largest Rivaroxaban Study To Date, Enrolled 27,395 Patients To Investigate CAD And PAD     8/28/2017
Bay Area's Avinger Shows Off 2-Year Pantheris Study Data     6/1/2017
FDA Grants Market Clearance to RA Medical's New PAD System     5/30/2017
Medtronic (MDT) Shows Off Drug-Coated Balloon in PAD Patients     4/25/2017
Symic Biomedical Announces Last Patient Enrolled In SHIELD Trial Of SB-030 For Interventions In Peripheral Artery Disease     2/24/2017
PQ Bypass Release: Company Announces Positive Results From DETOUR I Study At LINC 2017     1/24/2017
Intact Vascular Closes On Additional Series B Funding To Advance Development Of The Tack Endovascular System For Peripheral Artery Disease Treatment     1/3/2017
Shockwave Medical Announces Positive Six-Month DISRUPT PAD Results In Patients With Calcified Peripheral Artery Disease     9/19/2016
FDA Clears Shockwave Medical's Lithoplasty System, the First-Ever Device That Uses Sound Waves for Peripheral Artery Disease     9/16/2016
W. L. Gore & Associates VIABAHN Endoprosthesis Marks 20 Years Of Proven Performance     9/7/2016
Shockwave Medical Announces Positive Study Results Of Novel Lithoplasty System To Treat Peripheral Artery Disease     4/27/2016
Proteon (PRTO) Announces Publication In The Journal Of Cardiovascular Pharmacology Of Promising Nonclinical Results For Vonapanitase In Peripheral Artery Disease     4/13/2016
Profusa Awarded $1.75M NIH Grant To Further Develop Tissue-Integrated Biosensors For Continuous Oxygen Monitoring In PAD Patients     4/11/2016
SurModics (SRDX) Announces First Patient Enrolled In IDE Study Of Surveil Drug-Coated Balloon     4/6/2016
Holy Name Medical Center Enrolls First U.S. Patient In Ground-Breaking Gene Therapy Clinical Trial     2/5/2016